ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
237.27
+5.69 (2.46%)
At close: Dec 20, 2024, 4:00 PM
233.23
-4.04 (-1.70%)
After-hours: Dec 20, 2024, 7:00 PM EST
ResMed Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | 1,113 | 1,021 | 897.56 | 779.44 | 474.51 | 621.67 | Upgrade
|
| Depreciation & Amortization | 189.56 | 188.76 | 172.51 | 158.3 | 146.19 | 140.35 | Upgrade
|
| Other Amortization | 26.92 | 27.45 | 25.06 | 35.55 | 40.23 | 41.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 33.24 | 33.24 | 9.18 | - | 13.77 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 4.12 | 4.05 | -9.92 | 12.2 | -14.52 | 14.52 | Upgrade
|
| Loss (Gain) on Equity Investments | -3.01 | 1.85 | 10.14 | 8.49 | 11.21 | 25.06 | Upgrade
|
| Stock-Based Compensation | 81.83 | 80.18 | 71.14 | 65.26 | 63.93 | 57.56 | Upgrade
|
| Other Operating Activities | - | - | -20.23 | - | - | -0.01 | Upgrade
|
| Change in Accounts Receivable | -104.4 | -134.28 | -106.51 | 19.35 | -129.2 | 54.38 | Upgrade
|
| Change in Inventory | 75.04 | 172.2 | -248.83 | -311.68 | -21.95 | -69.88 | Upgrade
|
| Change in Accounts Payable | 97.65 | 122.07 | 31.34 | -247.63 | 210.71 | -23.42 | Upgrade
|
| Change in Other Net Operating Assets | -73.32 | -115.21 | -138.13 | -168.11 | -58.15 | -59 | Upgrade
|
| Operating Cash Flow | 1,441 | 1,401 | 693.3 | 351.15 | 736.72 | 802.26 | Upgrade
|
| Operating Cash Flow Growth | 54.08% | 102.11% | 97.44% | -52.34% | -8.17% | 74.76% | Upgrade
|
| Capital Expenditures | -87.27 | -99.46 | -119.67 | -134.84 | -102.71 | -95.33 | Upgrade
|
| Cash Acquisitions | -30.28 | -133.46 | -1,013 | -42.78 | -39.07 | -27.91 | Upgrade
|
| Sale (Purchase) of Intangibles | -6.33 | -15.4 | -14.33 | -21.2 | -14.11 | -10.61 | Upgrade
|
| Investment in Securities | -5.56 | -11.77 | -28.29 | -13.92 | -21.79 | -31.62 | Upgrade
|
| Other Investing Activities | 10.78 | -9.7 | 15.2 | -17.18 | 19.22 | -14.4 | Upgrade
|
| Investing Cash Flow | -118.66 | -269.78 | -1,160 | -229.92 | -158.46 | -179.86 | Upgrade
|
| Long-Term Debt Issued | - | 105 | 1,070 | 288 | 90 | 1,190 | Upgrade
|
| Long-Term Debt Repaid | - | -835 | -405 | -166 | -612 | -1,284 | Upgrade
|
| Net Debt Issued (Repaid) | -680 | -730 | 665 | 122 | -522 | -94.01 | Upgrade
|
| Issuance of Common Stock | 60.49 | 53.09 | 49.14 | 47.38 | 37.79 | 48.18 | Upgrade
|
| Repurchase of Common Stock | -208.94 | -158.77 | -30.63 | -52.41 | -50.21 | -46.06 | Upgrade
|
| Common Dividends Paid | -289.61 | -282.32 | -258.28 | -245.34 | -226.71 | -225.09 | Upgrade
|
| Other Financing Activities | -0.86 | -1.29 | -2.36 | - | -3.5 | -0.3 | Upgrade
|
| Financing Cash Flow | -1,119 | -1,119 | 422.87 | -128.36 | -764.63 | -317.29 | Upgrade
|
| Foreign Exchange Rate Adjustments | 14.32 | -1.72 | -2.15 | -14.43 | 18.5 | 10.92 | Upgrade
|
| Net Cash Flow | 217.26 | 10.47 | -45.82 | -21.57 | -167.88 | 316.03 | Upgrade
|
| Free Cash Flow | 1,353 | 1,302 | 573.63 | 216.31 | 634.01 | 706.93 | Upgrade
|
| Free Cash Flow Growth | 66.19% | 126.94% | 165.19% | -65.88% | -10.31% | 81.10% | Upgrade
|
| Free Cash Flow Margin | 28.15% | 27.78% | 13.58% | 6.05% | 19.83% | 23.91% | Upgrade
|
| Free Cash Flow Per Share | 9.17 | 8.82 | 3.89 | 1.47 | 4.33 | 4.85 | Upgrade
|
| Cash Interest Paid | 38.1 | 45.71 | 47.38 | 22.31 | 23.99 | 40.38 | Upgrade
|
| Cash Income Tax Paid | 307.36 | 278.4 | 216.87 | 478.12 | 221.36 | 180.36 | Upgrade
|
| Levered Free Cash Flow | 1,121 | 1,185 | 400.59 | 127.68 | 779.72 | 577.51 | Upgrade
|
| Unlevered Free Cash Flow | 1,143 | 1,216 | 432.55 | 141.63 | 794.48 | 602.1 | Upgrade
|
| Change in Net Working Capital | -11.92 | -169.35 | 422.15 | 587.78 | -87.49 | 36.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.